What is Choloxin used for?

Choloxin is indicated for Hyperlipidemia.

Choloxin is developed by AbbVie.

What development phase is Choloxin in?

Choloxin is FDA-approved (marketed).

What is the generic name of Choloxin?

DEXTROTHYROXINE is the generic (nonproprietary) name of Choloxin.

Last reviewed 2026-04-20 · How we verify

Choloxin (DEXTROTHYROXINE)

AbbVie · FDA-approved approved Small molecule Quality 21/100

Choloxin (Dextrothroxine) is a small molecule drug developed by AbbVie that targets the thyroid hormone receptor. It was approved by the FDA in 1967 for the treatment of hyperlipidemia. As an off-patent medication with no active Orange Book patents, Choloxin is available in its branded form only. Key safety considerations include its potential effects on thyroid function and lipid profiles. Choloxin's commercial status and availability may be subject to regional regulations.

At a glance

Generic name	DEXTROTHYROXINE
Sponsor	AbbVie
Drug class	dextrothyroxine
Target	Thyroid hormone receptor
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved
First approval	1967

Approved indications

Hyperlipidemia

Common side effects

No common side effects on file.

Key clinical trials

Coronary Drug Project (PHASE3)
Coronary Drug Project Mortality Surveillance (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results